Cinvanti® will be non-preferred effective April 3, 2025

Cinvanti® will be non-preferred effective April 3, 2025

Effective April 3, 2025, Cinvanti® will once again be a non-preferred agent in the Antiemetic 5-HT3 and NK1 Agents, Injectable PDL Edit.  Cinvanti was temporarily changed to a preferred agent last fall during the shortage on IV fluids following the effects of Hurricane Helene in North Carolina. Baxter stated in their February 17, 2025 update that manufacturing has now returned to pre-hurricane levels.

2025 Optimizing Benefits for Maternal and Infant Health Meetings

2025 Optimizing Benefits for Maternal and Infant Health Meetings

All MO HealthNet providers and professional community partners are invited to join the MO HealthNet Division, our Managed Care health plans, Show-Me ECHO, and the Office of Oral Health for a unique in-person networking opportunity in cities across Missouri.

Attendees will learn about valuable benefits, incentives, and resources available to pregnant women and their families, including individualized case management, Doula coverage, Non-Emergency Medical Transportation, and more.

MO HealthNet Pharmacy and Medical Pre-Certification Helpdesk IVR

MO HealthNet Pharmacy and Medical Pre-Certification Helpdesk IVR

Instantly Check PA Fax Status on the MHD Pharmacy and Medical Pre-Certification Helpdesk

MO HealthNet has introduced a convenient self-service feature on the MHD Pharmacy and Medical Pre-Certification Helpdesk IVR. Pharmacies and providers can now quickly check the status of their drug prior authorization (PA) fax requests using the National Provider Identifier (NPI), Participant’s Designated Client Number (DCN), and Fax Date.

MO HealthNet Participants with Third Party Liability Coverage

MO HealthNet Participants with Third Party Liability Coverage

Before requesting prior authorization (PA) from the MO HealthNet Division (MHD) for any medication, please verify whether the participant has any other third-party liability (TPL). Providers must utilize all available third-party benefits, including exploring therapeutic alternatives, pursuing prior authorization through the third-party payer, and utilizing a preferred pharmacy before MHD will consider reviewing PAs for participants with TPL.

Subscribe to All MO HealthNet Providers